Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Academic, Foundation, and Industry Collaboration in Finding New Therapies.

Literature DB >> 28467868

Academic, Foundation, and Industry Collaboration in Finding New Therapies.

Bonnie W Ramsey¹, Gerald T Nepom¹, Sagar Lonial¹.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Year: 2017 PMID： 28467868 PMCID： PMC5912685 DOI： 10.1056/NEJMra1612575

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

39 in total

1. The path to personalized medicine.

Authors: Margaret A Hamburg; Francis S Collins
Journal: N Engl J Med Date: 2010-06-15 Impact factor: 91.245

Review 2. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Authors: M J Welsh; A E Smith
Journal: Cell Date: 1993-07-02 Impact factor: 41.582

3. Precision Medicine: At What Price?

Authors: Thomas Ferkol; Paul Quinton
Journal: Am J Respir Crit Care Med Date: 2015-09-15 Impact factor: 21.405

4. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

Authors: B G Harvey; P L Leopold; N R Hackett; T M Grasso; P M Williams; A L Tucker; R J Kaner; B Ferris; I Gonda; T D Sweeney; R Ramalingam; I Kovesdi; S Shak; R G Crystal
Journal: J Clin Invest Date: 1999-11 Impact factor: 14.808

5. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors: J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal: Science Date: 1989-09-08 Impact factor: 47.728

6. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Authors: Ashley Pinckney; Mark R Rigby; Lynette Keyes-Elstein; Carol L Soppe; Gerald T Nepom; Mario R Ehlers
Journal: Clin Ther Date: 2016-05-18 Impact factor: 3.393

7. Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.

Authors: Paul G Richardson; David S Siegel; Ravi Vij; Craig C Hofmeister; Rachid Baz; Sundar Jagannath; Christine Chen; Sagar Lonial; Andrzej Jakubowiak; Nizar Bahlis; Kevin Song; Andrew Belch; Noopur Raje; Chaim Shustik; Suzanne Lentzsch; Martha Lacy; Joseph Mikhael; Jeffrey Matous; David Vesole; Min Chen; Mohamed H Zaki; Christian Jacques; Zhinuan Yu; Kenneth C Anderson
Journal: Blood Date: 2014-01-13 Impact factor: 22.113

8. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.

Authors: David S Siegel; Thomas Martin; Michael Wang; Ravi Vij; Andrzej J Jakubowiak; Sagar Lonial; Suzanne Trudel; Vishal Kukreti; Nizar Bahlis; Melissa Alsina; Asher Chanan-Khan; Francis Buadi; Frederic J Reu; George Somlo; Jeffrey Zonder; Kevin Song; A Keith Stewart; Edward Stadtmauer; Lori Kunkel; Sandra Wear; Alvin F Wong; Robert Z Orlowski; Sundar Jagannath
Journal: Blood Date: 2012-07-25 Impact factor: 22.113

Review 9. Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.

Authors: Jane H Buckner; Gerald T Nepom
Journal: J Autoimmun Date: 2016-03-03 Impact factor: 7.094

10. Gene integrated set profile analysis: a context-based approach for inferring biological endpoints.

Authors: Jeanne Kowalski; Bhakti Dwivedi; Scott Newman; Jeffery M Switchenko; Rini Pauly; David A Gutman; Jyoti Arora; Khanjan Gandhi; Kylie Ainslie; Gregory Doho; Zhaohui Qin; Carlos S Moreno; Michael R Rossi; Paula M Vertino; Sagar Lonial; Leon Bernal-Mizrachi; Lawrence H Boise
Journal: Nucleic Acids Res Date: 2016-01-29 Impact factor: 16.971

18 in total

1. Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials. Bridging Clinical and Patient Perspectives.

Authors: Salman Siddiqui; Loren C Denlinger; Stephen J Fowler; Praveen Akuthota; Dominick E Shaw; Liam G Heaney; Louise Brown; Mario Castro; Tonya A Winders; Monica Kraft; Scott Wagers; Michael C Peters; Ian D Pavord; Samantha Walker; Nizar N Jarjour
Journal: Am J Respir Crit Care Med Date: 2019-04-01 Impact factor: 21.405

Review 2. From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research.

Authors: José M de la Torre Hernández; Elazer R Edelman
Journal: Rev Esp Cardiol (Engl Ed) Date: 2017-08-31

3. Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials.

Authors: Taylor Bucy; John M Zoscak; Motomi Mori; Uma Borate
Journal: Blood Adv Date: 2019-12-10

4. Advancing Innovation in Skilled Nursing Facilities through Academic Collaborations.

Authors: Allison M Gustavson; Rebecca S Boxer; Amy Nordon-Craft; Robin L Marcus; Andrea Daddato; Jennifer E Stevens-Lapsley
Journal: Phys Ther J Policy Adm Leadersh Date: 2018-08

5. A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study.

Authors: R Mark Payne; Kristin M Burns; Andrew C Glatz; Danshi Li; Xiaodong Li; Paul Monagle; Jane W Newburger; Elizabeth A Swan; Olivia Wheaton; Christoph Male
Journal: Am Heart J Date: 2019-08-09 Impact factor: 4.749

Review 9. Getting Digital Assets from Public-Private Partnership Research Projects through "The Valley of Death," and Making Them Sustainable.

Authors: Wendy Aartsen; Paul Peeters; Scott Wagers; Bryn Williams-Jones
Journal: Front Med (Lausanne) Date: 2018-03-09

Review 10. Ethical Issues in Care and Treatment of Neuronal Ceroid Lipofuscinoses (NCL)-A Personal View.

Authors: Alfried Kohlschütter
Journal: Front Neurol Date: 2021-06-25 Impact factor: 4.003